MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma.
Yang M, Zhang T, Zhang Y, Ma X, Han J, Zeng K, Jiang Y, Wang Z, Wang Z, Xu J, et al. J Exp Clin Cancer Res. 2021 May 12; 40(1):166. Epub 2021 May 12.